VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
BIO
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
BIOBio-Rad Laboratories, Inc.
$292.50$7.9B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksBIOQuarterly Financials

Bio-Rad Laboratories, Inc. (BIO) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Bio-Rad Laboratories, Inc. (BIO) quarterly income statement — complete revenue, gross profit & net income history

BIO Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue592.1M693.2M653M651.6M585.4M667.48M649.73M638.48M610.82M681.18M632.12M681.11M676.84M730.29M680.8M691.1M700.06M732.77M747.05M715.93M
Revenue Growth %1.14%3.85%0.5%2.06%-4.16%-2.01%2.79%-6.26%-9.75%-6.72%-7.15%-1.45%-3.32%-0.34%-8.87%-3.47%-3.68%-7.23%15.42%33.35%
Cost of Goods Sold282.7M348M309.6M306.3M279.4M325.56M293.83M282.76M284.35M315.28M296.44M318.63M314.43M333.19M307.01M295.12M297.43M331.77M309.61M314.33M
COGS % of Revenue47.75%50.2%47.41%47.01%47.73%48.78%45.22%44.29%46.55%46.28%46.9%46.78%46.45%45.62%45.1%42.7%42.49%45.28%41.44%43.91%
Gross Profit309.4M345.2M343.4M345.3M306M341.91M355.9M355.12M326.47M365.9M335.68M362.48M362.42M397.1M373.79M395.98M402.63M401M437.44M401.6M
Gross Margin %52.25%49.8%52.59%52.99%52.27%51.22%54.78%55.62%53.45%53.72%53.1%53.22%53.55%54.38%54.9%57.3%57.51%54.72%58.56%56.09%
Gross Profit Growth %1.11%0.96%-3.51%-2.77%-6.27%-6.56%6.02%-2.03%-9.92%-7.86%-10.2%-8.46%-9.99%-0.97%-14.55%-1.4%0.5%-12.86%19.09%37.07%
Operating Expenses275.3M282.3M278.1M268.2M282.3M283.58M291.44M253.62M274.46M268.11M244.73M272.87M300.5M278.43M281M275.76M256.23M294.02M280.63M276.82M
OpEx % of Revenue46.5%40.72%42.59%41.16%48.22%42.49%44.86%39.72%44.93%39.36%38.72%40.06%44.4%38.13%41.27%39.9%36.6%40.12%37.57%38.67%
Selling, General & Admin212.4M216.6M206.8M207.7M208.8M204M200.44M196.12M210.48M205.9M201.2M207.82M225.55M212.23M211.05M208.73M196.69M224.15M216.15M213.43M
SG&A % of Revenue35.87%31.25%31.67%31.88%35.67%30.56%30.85%30.72%34.46%30.23%31.83%30.51%33.32%29.06%31%30.2%28.1%30.59%28.93%29.81%
Research & Development62.9M65.7M71.3M60.5M73.5M79.62M91M59.3M63.98M62.21M43.53M65.04M74.95M66.2M69.95M67.03M59.53M69.87M64.48M63.39M
R&D % of Revenue10.62%9.48%10.92%9.28%12.56%11.93%14.01%9.29%10.47%9.13%6.89%9.55%11.07%9.06%10.27%9.7%8.5%9.54%8.63%8.85%
Other Operating Expenses00000-42K0-1000K0000000000-579K-96K
Operating Income34.1M61.9M66.4M77.1M23.7M58.33M64.47M101.5M52.01M97.79M90.95M89.62M61.91M118.67M92.8M120.22M146.41M106.98M156.8M124.78M
Operating Margin %5.76%8.93%10.17%11.83%4.05%8.74%9.92%15.9%8.51%14.36%14.39%13.16%9.15%16.25%13.63%17.39%20.91%14.6%20.99%17.43%
Operating Income Growth %43.88%6.12%3%-24.04%-54.43%-40.35%-29.12%13.26%-16%-17.59%-1.99%-25.45%-57.71%10.93%-40.82%-3.66%45.16%-38.95%43.07%141.16%
EBITDA-677.5M114.3M120.6M127.7M61.8M107.63M113.57M148.1M99.81M150.79M139.05M147.22M107.51M168.74M127.1M162.82M179.81M140.68M200.2M168.28M
EBITDA Margin %-114.42%16.49%18.47%19.6%10.56%16.12%17.48%23.2%16.34%22.14%22%21.61%15.88%23.11%18.67%23.56%25.68%19.2%26.8%23.51%
EBITDA Growth %-1196.28%6.2%6.19%-13.77%-38.08%-28.62%-18.33%0.6%-7.17%-10.64%9.4%-9.58%-40.21%19.94%-36.52%-3.25%25.42%-33.46%39.81%94.68%
D&A (Non-Cash Add-back)052.4M54.2M50.6M38.1M49.3M49.1M46.6M47.8M53M48.1M57.6M45.6M50.07M34.3M42.6M33.4M33.7M43.4M43.5M
EBIT-677.5M61.9M66.4M426.6M95.4M-896.7M873.79M-2.77B503.36M440.75M149.5M-1.49B97.17M1.1B-195.66M-1.21B-4.36B-2.04B5.02B1.16B
Net Interest Income-12.3M18.9M1.4M2.1M24.2M3.71M3.33M4.34M21.72M4.44M4.9M4.16M37.96M617K-3.66M-5.22M28.15M-164K-726K337K
Interest Income031M13.7M14.7M36.2M15.9M15.5M16.6M34M16.8M17.3M16.5M50.3M12.3M8M5.5M32.2M200K-300K700K
Interest Expense12.3M12.1M12.3M12.6M12M12.19M12.17M12.26M12.28M12.36M12.4M12.34M12.34M11.68M11.66M10.72M4.05M364K426K363K
Other Income/Expense-723.9M867.3M-497.5M336.9M59.7M-967.23M797.15M-2.89B439.07M330.6M46.15M-1.59B22.92M972.61M-301.96M-1.34B-4.51B-2.15B4.87B1.03B
Pretax Income-689.8M929.2M-431.1M414M83.4M-908.9M861.62M-2.79B491.08M428.39M137.1M-1.5B84.83M1.09B-209.17M-1.22B-4.37B-2.04B5.02B1.16B
Pretax Margin %-116.5%134.04%-66.02%63.54%14.25%-136.17%132.61%-436.4%80.4%62.89%21.69%-220.29%12.53%149.43%-30.72%-176.95%-623.95%-278.13%672.28%161.58%
Income Tax-162.7M209.2M-89.2M96.2M19.4M-193.1M208.45M-620.79M107.16M78.68M30.84M-338.18M15.87M263.55M-44.94M-295.7M-1B-464.4M1.09B242.66M
Effective Tax Rate %23.59%22.51%20.69%23.24%23.26%21.25%24.19%22.28%21.82%18.37%22.5%22.54%18.7%24.15%21.48%24.18%22.91%22.79%21.79%20.98%
Net Income-527.1M720M-341.9M317.8M64M-715.8M653.17M-2.17B383.92M349.71M106.26M-1.16B68.96M833.49M-164.23M-927.18M-3.37B-1.57B3.93B914.11M
Net Margin %-89.02%103.87%-52.36%48.77%10.93%-107.24%100.53%-339.16%62.85%51.34%16.81%-170.64%10.19%114.13%-24.12%-134.16%-481.01%-214.76%525.81%127.68%
Net Income Growth %-923.59%200.59%-152.34%114.68%-83.33%-304.69%514.71%-86.32%456.71%-58.04%164.7%-25.35%102.05%152.97%-104.18%-201.43%-444.52%-287.54%198.75%-5.41%
Net Income (Continuing)-527.1M720M-341.9M317.8M64M-715.8M653.17M-2.17B383.92M349.71M106.26M-1.16B68.96M827.73M-164.23M-927.18M-3.37B-1.57B3.93B914.11M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-19.5526.65-12.7011.672.29-25.5723.34-76.2613.4512.143.64-39.592.3227.78-5.52-31.12-112.57-52.59129.9630.32
EPS Growth %-953.71%204.22%-154.41%115.3%-82.97%-310.63%541.21%-92.62%479.74%-56.3%165.94%-27.22%102.06%152.82%-104.25%-202.64%-447.65%-289.1%197.8%-5.69%
EPS (Basic)-19.5526.69-12.7011.672.29-25.5723.37-76.2613.4612.153.65-39.592.3327.89-5.53-31.12-112.58-52.59131.7530.71
Diluted Shares Outstanding26.96M27.01M26.92M27.23M27.95M28M27.98M28.39M28.54M28.82M29.22M29.36M29.75M29.79M29.73M29.79M29.93M29.92M30.22M30.15M
Basic Shares Outstanding26.96M26.98M26.92M27.23M27.94M28M27.95M28.39M28.52M28.79M29.1M29.36M29.6M29.68M29.71M29.79M29.93M29.92M29.81M29.76M
Dividend Payout Ratio--------------------